Examining Heart Failure Treatments: Semaglutide vs. Tirzepatide

This chapter explores a study on the effectiveness of semaglutide and tirzepatide in treating heart failure with preserved ejection fraction, using an innovative emulation of randomized trials. The findings reveal that both drugs significantly reduce hospitalization and mortality rates, though no substantial differences were noted between them, emphasizing the potential of clinical trial emulation in research.